Shanghai Sanyou Medical Co Ltd (688085) — Capital Reinvestment Ratio

Latest as of September 2025: 0.08x

Shanghai Sanyou Medical Co Ltd (688085) has a Capital Reinvestment Ratio of 0.08x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥34.19 Million) in capital expenditures (CN¥2.87 Million). See Shanghai Sanyou Medical Co Ltd balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.08x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥34.19 Million
CNY

Capital Expenditures

CN¥2.87 Million
CNY

Data as of

Sep 2025
Most recent filing

Shanghai Sanyou Medical Co Ltd Capital Reinvestment Ratio (2016–2024)

This chart tracks Shanghai Sanyou Medical Co Ltd's Capital Reinvestment Ratio across 9 annual periods. Check how aggressively does Shanghai Sanyou Medical Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Shanghai Sanyou Medical Co Ltd (2016–2024)

Year-by-year Capital Reinvestment Ratio for Shanghai Sanyou Medical Co Ltd from 2016 to 2024. For live market cap and broader valuation context, see 688085 market cap.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 3.41x CN¥10.96 Million CN¥37.44 Million ▲ +3420.3%
2023 0.10x CN¥267.43 Million CN¥25.94 Million ▼ -89.1%
2022 0.89x CN¥155.97 Million CN¥138.20 Million ▲ +40.1%
2021 0.63x CN¥144.92 Million CN¥91.66 Million ▲ +61.0%
2020 0.39x CN¥77.52 Million CN¥30.45 Million ▼ -69.6%
2019 1.29x CN¥61.72 Million CN¥79.69 Million ▼ -57.8%
2018 3.06x CN¥19.79 Million CN¥60.56 Million ▲ +80.0%
2017 1.70x CN¥21.54 Million CN¥36.62 Million ▲ +904.2%
2016 0.17x CN¥19.39 Million CN¥3.28 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow